(This article was created in collaboration with Claude AI.)
Key Takeaways:
• Healthcare Is Becoming Unaffordable. Healthcare experts worry that healthcare costs are rising dramatically faster than wages and tax revenues, making care unaffordable for some Americans.
• The Payment Model Is Broken. Current year-to-year employer coverage creates incentives where companies pay for preventive care, but employees are likely to leave jobs before seeing benefits.
• Cost Transparency Is Missing. Healthcare pricing can lack transparency, with identical procedures varying dramatically in cost, even in facilities across the street from each other. This can make it difficult for patients to make informed decisions.
• Evidence Takes Too Long. It can take 20 years for breakthrough research in journals to reach everyday medical practice, a timeline that experts say needs to be shortened.
• Innovation Faces Regulatory Hurdles. The gap between FDA approval for safety and efficacy versus coverage decisions by payers may create barriers even for scientifically validated treatments.
At DOC 2024’s healthcare finance panel, “What Capital Wants,” the discussion brought together healthcare and venture experts alongside leaders focused on the role of money in the healthcare system. As DOC’s John Battelle framed the central question: how companies get funded and how they make money drives everything else in healthcare innovation. The discussion, moderated by Brenton Fargnoli, AlleyCorp’s former General Partner leading the healthcare team, brought together Dr. Kavita Patel, a primary care physician and venture partner with NEA, alongside Lois Quam, then-President of Blue Shield of California.
The conversation revealed a stark disconnect between scientific possibility and financial reality. Patel painted a picture of exciting frontiers in longevity science, from brain-computer interfaces to women’s hormonal health monitoring. Yet when pressed about implementation, she acknowledged the reality: it would be a long time before many of these advanced tests make their way to everyday medical practice.
The fundamental barrier is cost. Quam explained that healthcare is becoming out of reach for ordinary Americans, where even the act of seeking healthcare can financially harm families. This crisis extends far beyond drug prices to encompass all aspects of care, including preventative and diagnostic services.
An audience member, identifying as a physician, illustrated the problem with a striking example: an MRI costs $7,500 at his hospital but $500 across the road, with no transparency for patients. Even with platinum insurance, he explained, high co-pays made certain medical treatments unaffordable for him personally.
The solutions being explored attack the problem from multiple angles. Patel, for example, identified a fundamental mismatch in the current employer-based insurance model. Companies invest in preventive care today, but employees often change jobs before health benefits materialize years later. This disconnect undermines long-term health investments and perpetuates a system focused on treating disease rather than preventing it.
Adding to the implementation challenges, Patel noted it can take up to 20 years for breakthrough research published in major medical journals to reach everyday clinical practice — a timeline, she argued, must be shortened.
Even when treatments have strong scientific backing, financial and regulatory barriers persist. Patel explained that while treatments may earn FDA approval based on safety and efficacy, coverage decisions by Medicare, for example, can create additional hurdles. The “reasonable and necessary” standard sounds broad but becomes narrow when actuaries and cost considerations enter the picture.
The session’s underlying message was clear — the same intensity that drives scientific breakthroughs must be applied to cost-reducing healthcare innovations, given the financial constraints facing the economy, government systems, and families.